Table 1. Stability analysis of ¹¹¹In-labeled 3-arm and 4-arm DOTA-α-MSH in plasma, liver, and kidney of mice by ex vivo.

	Time (min)	10	30	60	120	180
111In labeled 3-arm DOTA-α-MSH	Plasma (%)	96.1 ± 2.0	95.1 ± 1.8	86.4 ± 2.5	79.2 ± 2.2	73.5 ± 2.4
	Liver (%)	95.7 ± 2.1	95.5 ± 1.9	84.3 ± 2.2	71.6 ± 4.5	62.9 ± 6.7
	Kidney (%)	95.8 ± 2.0	95.9 ± 1.7	85.7 ± 2.8	78.5 ± 2.7	74.3 ± 4.1
111In labeled 4-arm DOTA-α-MSH	Plasma (%)	96.0 ± 2.5	95.8 ± 2.6	92.1 ± 2.1	84.2 ± 2.2	80.8 ± 2.3
	Liver (%)	95.1 ± 2.9	94.9 ± 2.1	91.3 ± 3.2	78.6 ± 4.9	76.2 ± 4.1
	Kidney (%)	96.1 ± 2.0	95.8 ± 1.9	93.3 ± 3.5	84.5 ± 3.3	80.5 ± 2.8

All data are the mean ± standard deviation from triplicate measurements using three mice per time point

https://doi.org/10.6084/m9.figshare.7697815